secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2021-12-08T23:59:59+00:00
Accession:  0001193125-21-350898
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corcept wins patent appeal, discloses DOJ subpoena on Korlym sales, extends tender offer to Dec 15
--------------------------------------------------------------------------------

- Federal Circuit affirmed PTAB decision upholding validity of '214 patent (expires 2037) against Teva challenge.
- Received HIPAA subpoena from NJ USAO regarding Korlym sales and HCP payments; investigating potential criminal/civil violations; Corcept not a defendant.
- Extended tender offer expiration to Dec 15, 2021; 8,282,336 shares tendered to date; condition of at least 3M shares tendered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000119312521350898/0001193125-21-350898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000119312521350898/d255329d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-350898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer